My endo and I disagree about glp-1 receptor agonists and thyroid c-cell and I want a reality check.

They are saying that I do not need to worry about it but everything I have read here suggests otherwise.

I trust this community's collective knowledge but I also do not want to go against medical advice without good reason. What would you do?

To answer the question about GLP-1 receptor agonists and thyroid C-cell concerns what worked for you? — in my experience this comes down to a few key factors.

I have been dealing with this for over a year now, and what I have found is that individual responses really do vary. That said, the general consensus on GLP-1 receptor agonists and seems solid.

What specifically worked for me: getting baseline labs before making any changes. I would suggest pam_columbus try the same approach and reporting back.

PurityPaulOR said:

— in my experience this comes down to a few key factors

Completely agree with PurityPaulOR. I would add that GLP-1 receptor agonists and also has implications for long-term metabolic health that sometimes get overlooked in these discussions.

In my case, following a similar approach led to significant improvements compared to what I was doing before.

Subscribing to this thread. GLP-1 receptor agonists is exactly what I've been researching. 🙏

As a pharmacist, I want to add some clinical context to this discussion on GLP-1 receptor agonists and thyroid.

Building on what pam_columbus said — the evidence base here is robust. The key publications to reference are from the FLOW program[1].

Key clinical points:

1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
2. Side effect profile is predictable and usually manageable with standard protocols
3. Monitoring should include baseline labs and follow-up at 3-month intervals
4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.